How to invest in shares to help beat inflation

Inflation in the UK is currently up around 9%. And it’s widely tipped to climb into double digits. Finding shares to beat inflation, or at least help towards that goal, isn’t easy.

Companies in highly competitive markets are surely going to suffer. It means they don’t have much pricing power. We’ve seen a couple of examples recently. Motor insurer Sabre Insurance crashed after first-half results revealed a plunge in profits. The company put it down to “extraordinary inflationary pressures.”

Direct Line Insurance suffered similarly, also hit by inflationary costs. Its wider product range shielded it a little, but it was still painful.

One possible approach is to look for companies offering premium products with healthy margins. Hopefully, those should be more resilient in the face of inflation.

High margins

Diageo springs to mind, with its huge range of brands. It might appear to be up against plenty of competition in the alcoholic drinks market. But it’s surprising how many apparently competing brands are actually owned by Diageo itself.

It’s easy to misjudge the value of some of Diageo’s labels too. Johnnie Walker might just seem like one brand among hundreds. But in large parts of Asia it’s a prestigious one.


We can also try to stick with companies offering essential products and services, stuff that people can’t do without. Ideally, I like to see as little competition as possible too. After all, car insurance is an essential, but competition is strong.

BP and Shell seem to fit the bill. Both have seen their share prices climbing, and both are paying attractive dividends. There is one caution, though. It just happens that world events pushed the oil price up, and that’s behind the gains.

The escalating fuel price does play its part in inflation, mind. But it’s possible that oil might have nothing to do with our next inflationary spell. And a volatile oil price might even cause more damage to investors than inflation in the future.

Protective moats

National Grid looks resilient to me. It enjoys a bit of a monopoly in UK energy supply. And in inflationary times, energy providers can hardly look elsewhere for alternative routes to market. Water companies, like SSE, are in a similar position to National Grid.

Big pharmaceuticals firms like AstraZeneca and GSK also strike me as being resistant to rising prices. They research and develop patented blockbuster drugs. And they can adjust their pricing to deal with inflationary costs without fear of being undercut.

Long term

I think the best approach to beating inflation with our investments, though, is relatively straightforward. It can be very hard to find shares to keep us ahead of a year of 10% inflation. So I’m not even trying to do that.

Instead, I’m sticking to buying top-quality companies with competitive advantages. And I look for healthy cash flow to fund progressive dividends. I fully expect to lose out to inflation this year. But over the long term, I reckon my chances of beating it are high.

In fact, I’d say the best shares to buy to beat inflation over the long term are the exact same ones I’d buy anyway.

The post How to invest in shares to help beat inflation appeared first on The Motley Fool UK.

6 shares that we think could be the biggest winners of the stock market crash

The hotshot analysts at The Motley Fool UK’s flagship share-tipping service Share Advisor have just unveiled what they think could be the six best buys for investors right now.

And while timing isn’t everything, the average return of their previous stock picks shows that it could pay to get in early on their best ideas – particularly in this current climate!

What’s more, all six ‘Best Buys Now’ are available to access right now, in just a few clicks.

Learn more

setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFFFFF”, ‘color’, ‘#FFFFFF’);

More reading

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Diageo and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.